Lapeyre André C, St Gibson Wayne, Bashore Thomas M, Gibbons Raymond J
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Am Heart J. 2003 Jun;145(6):1051-7. doi: 10.1016/S0002-8703(03)00112-1.
Several techniques have been used to quantify the myocardium at risk, including measurement of regional ventricular function with contrast ventriculography and measurement of perfusion defect size with tomographic technetium-99m-sestamibi imaging. This study evaluates the correlation between these 2 techniques.
Twenty-three patients with angiographically documented coronary occlusion and acute myocardial infarctions (10 anterior, 13 inferior) were studied. All patients had contrast left ventriculography at the time of their acute angiogram before any revascularization therapy. Regional wall motion parameters measured with the centerline method were the severity, circumferential extent, and global circumferential extent of hypokinesis and the mean standardized motion in predefined areas. Technetium-99m-sestamibi was injected before reperfusion therapy with measurement of the myocardium at risk using single photon emission computed tomography imaging.
The tomographic sestamibi-measured myocardium at risk was significantly greater for anterior infarctions compared with inferior infarctions (40% +/- 18% vs 14.0 +/- 8.5%, P =.0001). The only parameter of regional wall motion to show a significant difference by infarct location was global circumferential extent of hypokinesis (43% +/- 25% vs 22% +/- 15%, P =.02). The other parameters were not significantly different between anterior and inferior myocardial infarctions. For anterior infarctions, these parameters of regional wall motion correlated with myocardium at risk assessed with sestamibi: global circumferential extent of hypokinesis (r =.88, P <.01), circumferential extent of hypokinesis (r =.78, P <.01), mean standardized motion in predefined areas (r = -.74, P <.05), and severity of hypokinesis (r = -.70, P <.05). For inferior infarctions, there was no significant correlation between any of these parameters of regional wall motion and myocardium at risk assessed with sestamibi imaging.
The assessment of regional ventricular function with contrast ventriculography correlates with the area of myocardium at risk measured with tomographic technetium-99m-sestamibi for anterior, but not for inferior, myocardial infarctions. Therefore, these parameters of regional wall motion are a poor measure of the efficacy of reperfusion therapies.
已经使用了多种技术来量化危险心肌,包括通过对比心室造影测量局部心室功能以及通过断层99m锝-甲氧基异丁基异腈成像测量灌注缺损大小。本研究评估这两种技术之间的相关性。
对23例经血管造影证实有冠状动脉闭塞和急性心肌梗死的患者(10例前壁梗死,13例下壁梗死)进行了研究。所有患者在急性血管造影时且在任何血运重建治疗之前均进行了对比左心室造影。用中心线法测量的局部壁运动参数包括运动减弱的严重程度、圆周范围、整体圆周范围以及预定义区域内的平均标准化运动。在再灌注治疗前注射99m锝-甲氧基异丁基异腈,并用单光子发射计算机断层成像测量危险心肌。
与下壁梗死相比,前壁梗死经断层甲氧基异丁基异腈测量的危险心肌明显更大(40%±18%对14.0±8.5%,P = 0.0001)。梗死部位显示有显著差异的唯一局部壁运动参数是运动减弱的整体圆周范围(43%±25%对22%±15%,P = 0.02)。前壁和下壁心肌梗死之间的其他参数无显著差异。对于前壁梗死,这些局部壁运动参数与用甲氧基异丁基异腈评估的危险心肌相关:运动减弱的整体圆周范围(r = 0.88,P < 0.01)、运动减弱的圆周范围(r = 0.78,P < 0.01)、预定义区域内的平均标准化运动(r = -0.74,P < 0.05)以及运动减弱的严重程度(r = -0.70,P < 0.05)。对于下壁梗死,这些局部壁运动参数中的任何一个与用甲氧基异丁基异腈成像评估的危险心肌之间均无显著相关性。
通过对比心室造影评估局部心室功能与通过断层99m锝-甲氧基异丁基异腈测量的前壁心肌梗死危险心肌面积相关,但与下壁心肌梗死无关。因此,这些局部壁运动参数对再灌注治疗疗效的评估价值不大。